Darren Wilbraham Selected Research

LY3154207

1/2022

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator, in Patients With Parkinson Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darren Wilbraham Research Topics

Disease

4	Migraine Disorders (Migraine) 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 08/2023 - 08/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2023
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Movement Disorders (Movement Disorder) 01/2022
1	Lewy Body Disease (Lewy Body Dementia) 01/2022
1	Bradycardia 01/2017
1	Atrioventricular Block 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Hyperpigmentation 03/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2013
1	Prostatic Neoplasms (Prostate Cancer) 02/2013
1	Sleep Wake Disorders 02/2013
1	Asthma (Bronchial Asthma) 10/2007
1	Inflammation (Inflammations) 10/2007

Drug/Important Bio-Agent (IBA)

5	lasmiditanIBA 08/2023 - 01/2020
2	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2023
1	Biomarkers (Surrogate Marker)IBA 08/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2023
1	Proteins (Proteins, Gene)FDA Link 08/2023
1	LY3154207IBA 01/2022
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2022
1	5-HT1F Serotonin ReceptorIBA 01/2020
1	Propranolol (Inderal)FDA LinkGeneric 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2020
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2017
1	amiselimodIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2017
1	VaccinesIBA 03/2014
1	Orexin Receptor AntagonistsIBA 02/2013
1	suvorexantIBA 02/2013
1	KisspeptinsIBA 02/2013
1	pitrakinraIBA 10/2007
1	AllergensIBA 10/2007
1	Interleukin-13IBA 10/2007
1	interleukin-4 variantIBA 10/2007
1	Therapeutic UsesIBA 10/2007
1	InterleukinsIBA 10/2007
1	Interleukin-4 (Interleukin 4)IBA 10/2007
1	CytokinesIBA 10/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 08/2023
1	Therapeutics 01/2020
1	Castration 02/2013